KD Logo

Chief Regulatory Officer Weber Darin J. sold 17,238 shares of ProKidney Corp [PROK]

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ProKidney Corp shares valued at $48,616 were sold by Weber Darin J. on Jun 18 ’24. At $2.82 per share, Weber Darin J. sold 17,238 shares. The insider’s holdings dropped to 120,718 shares worth approximately $0.31 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Legorreta Pablo G. purchased 22,617,909 shares, netting a total of over 54,735,340 in proceeds. Following the buying of shares at $2.42 each, the insider now holds 22,617,909 shares.

Before that, Weber Darin J. had sold 17,238 shares from its account. In a trade valued at $70,386, the Chief Regulatory Officer traded ProKidney Corp shares for $4.08 each. Upon closing the transaction, the insider’s holdings decreased to 17,238 shares, worth approximately $0.35 million.

Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early January. As of July 25, 2023, BTIG Research has initiated its “Buy” rating for PROK. Earlier on December 21, 2022, Jefferies initiated its rating. Their recommendation was “a Buy” for PROK stock.

Analyzing PROK Stock Performance

During the last five days, there has been a drop of approximately -14.38%. Over the course of the year, ProKidney Corp shares have jumped approximately 43.82%. Shares of the company reached a 52-week high of $4.44 on 05/20/24 and a 52-week low of $1.18 on 02/13/24. A 50-day SMA is recorded $2.89, while a 200-day SMA reached $2.48. Nevertheless, trading volume fell to 0.86 million shares from 0.41 million shares the previous day.

Support And Resistance Levels for ProKidney Corp (PROK)

According to the 24-hour chart, there is a support level at 2.42, which, if violated, would cause prices to drop to 2.28. In the upper region, resistance lies at 2.72. The next price resistance is at 2.89. RSI (Relative Strength Index) is 43.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.31, which suggests the price will decrease in the coming days. Percent R is at 77.32%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular